tirzepatide affirm Weight Loss Program — Dual GIP/GLP-1 Tirzepatide Weight Loss Spray

Personalizing dosing while considering existing medications and health conditions

At 72 weeks, adults receiving tirzepatide had a 0.6-point greater drop in PHQ-9 score than placebo

The chart below is a research-use-only reconstitution & dosage reference for the tirzepatide research compound not affiliated with, endorsed by, or a substitute for those approved medicines, and not medical advice

The form asks detailed questions about your medical history, including current weight, height, previous weight loss attempts, existing health conditions, medications you currently take, and any history of thyroid issues or pancreatitis

Maintaining my weight and feeling awesome

Theyre also subject to subject to strict limitations under Section 503A/503B of the FDCA